Craneware Regulatory News (CRW)

Craneware plc

("Craneware" or the "Company")

Grant of Share Options

21 April 2020 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, announces that on 20 April 2020, under the terms of the Craneware plc SAYE Option Plan (2018) ("the Option Plan"), share options (the "Options") to acquire ordinary shares of 1p each in the Company ("Shares") were granted to two Directors of the Company as follows:

The Option Plan is a UK all employee HMRC approved Save As You Earn option scheme. The Options were granted on the same terms as other UK employees who chose to participate in the Option Plan. The Options have been granted at an exercise price of £11.475 per Share. The Options will ordinarily become exercisable for a period of six months from the end of the savings term.

PDMR notification: Keith Neilson

1. Details of the Restricted Person / person closely associated with him or her

a) Name Keith Neilson

2. Reason for the notification

a) Position / status CEO

b) Initial notification / Amendment Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code ISIN GB00B2425G68

c) Nature of the transaction Grant of share option under the Craneware plc

SAYE Option Plan (2018)

d) Price(s) and volume(s) Volume(s) granted 1,568, Exercise Price(s) £11.475

e) Aggregated information: N/A (single transaction)

i. Aggregated volume -

ii. Price -

f) Date of the transaction 2020-04-20

g) Place of the transaction Outside a trading venue

PDMR notification: Craig Preston

1. Details of the Restricted Person / person closely associated with him or her

a) Name Craig Preston

2. Reason for the notification

a) Position / status CFO

b) Initial notification / Amendment Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code ISIN GB00B2425G68

c) Nature of the transaction Grant of share option under the Craneware plc

SAYE Option Plan (2018)

d) Price(s) and volume(s) Volume(s) granted 1,568, Exercise Price(s) £11.475

e) Aggregated information: N/A (single transaction)

i. Aggregated volume

ii. Price

f) Date of the transaction 2020-04-20

g) Place of the transaction Outside a trading venue

For further information, please contact:

About Craneware

Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor value-based economic performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's value cycle management suite includes charge capture, strategic pricing, patient engagement, claims analytics, revenue recovery and retention, and cost and margin intelligence solutions.

Learn more at www.craneware.com